The Connected Drug Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Connected Drug Delivery Devices Market?
The global market of connected drug delivery devices has been expanding considerably over the years. The market, which was valued at $7.48 billion in 2024, is predicted to reach $9.29 billion in 2025, growing at a compound annual growth rate (CAGR) of 24.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Connected Drug Delivery Devices Industry?
The connected drug delivery devices market is anticipated to grow significantly, reaching a market size of $21.92 billion in 2029. The market is expected to grow at a compound annual growth rate (CAGR) of 23.9%.
Download Your Free Sample of the 2025 Connected Drug Delivery Devices Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Connected Drug Delivery Devices Market?
The key drivers in the connected drug delivery devices market are:
• Rising prevalence of chronic diseases and increased patient awareness of adherence to prescribed therapies
• Rapid advancement and adoption of healthcare IT infrastructure
• Increasing focus on preventive care and widespread use of connected devices in healthcare settings for electronic health records
• A surge in research & development activities along with increased device connectivity, machine learning and artificial intelligence adoption.
Global Market Segmentation: Identifying Major Connected Drug Delivery Devices Industry Segments
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Pre-order the 2025 Connected Drug Delivery Devices Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Connected Drug Delivery Devices Market?
The key trends in the connected drug delivery devices market are:
• The trend of increasing research and development activities is shaping the future of the Connected Drug Delivery Devices market.
• There is a surge in technological innovation and the increasing connectivity of devices, influencing the market significantly.
• The soaring adoption of machine learning and artificial intelligence is a major emerging trend.
• The market is being considerably shaped by the rising implementation of telehealth platform integrated with AR/VR technologies and the increasing adoption of electronic technology in healthcare devices.
Who Are the Top Competitors & Leading Players in the Connected Drug Delivery Devices Market?
Major companies in the connected drug delivery devices market are:
• Pfizer Inc.
• Johnson & Johnson
• Bayer AG
• AstraZeneca PLC
• Abbott Laboratories
• Novartis AG
• Medtronic PLC
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Novo Nordisk A/S
• Merck Group
• Becton Dickinson and Company
• GlaxoSmithKline PLC
• Phillips-Medisize Corporation
• AptarGroup Inc.
• Dexcom Inc.
• West Pharmaceutical Services Inc.
• Insulet Corporation
• OPKO Health Inc.
• Tandem Diabetes Care Inc.
• Ypsomed AG
• Meridian Medical Technologies LLC
• Propeller Health
• Findair Sp. z.o.o.
Regional Dominance: Which Area Leads the Global Connected Drug Delivery Devices Market?
North America was the largest region in the connected drug delivery market in 2024
